Evaluation of Superior Rectal Arterial Embolization in Hemorrhoidal Disease

Recruiting N/A Interventional Study
Hemorrhoids
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
80 (estimated)
Sponsor
Universitair Ziekenhuis Brussel · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
SRAE is a promising treatment of bleeding HD as a minimally invasive approach without sphincter damage nor direct mucosal anorectal trauma. Feasibility, efficacy and safety were studied in several trials. A randomized controlled study should confirm the benefits of this technique and will define its therapeutic role in HD. Embolization and DG-HAL are based on the same concept of vascular occlusio…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All patients referred for Hemorrhoidal disease with bleeding are eligible. Significant bleeding is defined as a HBS of ≥ 5. * Age \> 18 years old; * Sexes eligible for study: all * Hemorrhoidal disease grade I-III according the Goligher classification with rectal bleeding as p…
Contacts

Magali Surmont

+32 2 477

magali.surmont@uzbrussel.be

CONTACT

Virgini Van Buggenhout

+32 2 477

virgini.vanbuggenhout@uzbrussel.be

CONTACT